Traws Pharma, Inc. (TRAW)
0.41
-0.01
(-1.44%)
USD |
NASDAQ |
Oct 13, 14:04
Traws Pharma Price to Book Value : 3.703 for Oct. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 3.757 |
| October 09, 2026 | 4.021 |
| October 08, 2026 | 4.338 |
| October 07, 2026 | 4.326 |
| October 06, 2026 | 4.696 |
| October 05, 2026 | 4.841 |
| October 02, 2026 | 5.134 |
| October 01, 2026 | 4.925 |
| September 30, 2026 | 5.363 |
| September 29, 2026 | 5.653 |
| September 28, 2026 | 5.229 |
| September 25, 2026 | 5.086 |
| September 24, 2026 | 5.057 |
| September 23, 2026 | 4.548 |
| September 22, 2026 | 4.516 |
| September 21, 2026 | 4.514 |
| September 18, 2026 | 4.425 |
| September 17, 2026 | 4.836 |
| September 16, 2026 | 4.815 |
| September 15, 2026 | 4.777 |
| September 14, 2026 | 4.686 |
| September 11, 2026 | 5.096 |
| September 10, 2026 | 4.80 |
| September 09, 2026 | 4.877 |
| September 08, 2026 | 4.990 |
| Date | Value |
|---|---|
| September 04, 2026 | 4.968 |
| September 03, 2026 | 4.895 |
| September 02, 2026 | 5.148 |
| September 01, 2026 | 5.328 |
| August 31, 2026 | 5.346 |
| August 28, 2026 | 5.327 |
| August 27, 2026 | 5.287 |
| August 26, 2026 | 5.428 |
| August 25, 2026 | 5.227 |
| August 24, 2026 | 5.057 |
| August 21, 2026 | 4.786 |
| August 20, 2026 | 4.696 |
| August 19, 2026 | 4.877 |
| August 18, 2026 | 4.877 |
| August 17, 2026 | 4.877 |
| August 14, 2026 | 5.157 |
| August 13, 2026 | 5.419 |
| August 12, 2026 | 4.814 |
| August 11, 2026 | 4.886 |
| August 10, 2026 | 4.877 |
| August 07, 2026 | 4.804 |
| August 06, 2026 | 4.868 |
| August 05, 2026 | 5.002 |
| August 04, 2026 | 4.997 |
| August 03, 2026 | 4.259 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.751 |
| Corcept Therapeutics, Inc. | 18.04 |
| Veru, Inc. | 1.376 |
| Johnson & Johnson | 7.019 |
| Eli Lilly & Co. | 32.35 |
Price to Book Value Related Metrics
| Price | 0.41 |
| Earnings Yield | -563.2% |
| Market Cap | 6.261M |